Disaggregating physiological components of cortisol output: A novel approach to cortisol analysis in a clinical sample - A proof-of-principle study.
Childhood adversity
Cortisol
Diurnal variation
Psychopathology
Stress-induction
Waking cortisol
Journal
Neurobiology of stress
ISSN: 2352-2895
Titre abrégé: Neurobiol Stress
Pays: United States
ID NLM: 101643409
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
14
07
2018
revised:
17
01
2019
accepted:
04
03
2019
entrez:
14
6
2019
pubmed:
14
6
2019
medline:
14
6
2019
Statut:
epublish
Résumé
Although childhood adversity (CA) increases risk for subsequent mental illnesses, developmental mechanisms underpinning this association remain unclear. The hypothalamic-pituitary-adrenal axis (HPAA) is one candidate system potentially linking CA with psychopathology. However, determining developmental effects of CA on HPAA output and differentiating these from effects of current illness has proven difficult. Different aspects of HPAA output are governed by differentiable physiological mechanisms. Disaggregating HPAA output according to its biological components (baseline tonic cortisol, background diurnal variation, phasic stress response) may improve precision of associations with CA and/or psychopathology. In a novel proof-of-principle investigation we test whether different predictors, CA (distal risk factor) and current depressive symptoms, show distinct associations with dissociable HPAA components. A clinical group (aged 16-25) at high-risk for developing severe psychopathology (n = 20) were compared to age and sex matched healthy controls (n = 21). Cortisol was measured at waking (x4), following stress induction (x8), and during a time-environment-matched non-stress condition. Using piecewise multilevel modeling, stress responses were disaggregated into increase and decrease, while controlling for waking cortisol, background diurnal output and confounding variables. Elevated waking cortisol was specifically associated with higher CA scores. Higher non-stress cortisol was specifically associated with higher depressive scores. Following stress induction, depressive symptoms attenuated cortisol increase, whilst CA attenuated cortisol decrease. The results support a differential HPAA dysregulation hypothesis where physiologically dissociable components of HPAA output are differentially associated with distal (CA) or proximal (depressive symptoms) predictors. This proof-of-principle study demonstrates that future cortisol analyses need to disaggregate biologically independent mechanisms of HPAA output.
Identifiants
pubmed: 31193494
doi: 10.1016/j.ynstr.2019.100153
pii: S2352-2895(18)30059-6
pii: 100153
pmc: PMC6535687
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100153Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Références
Schizophr Bull. 1999;25(3):553-76
pubmed: 10478789
Neuropsychopharmacology. 2000 Oct;23(4):411-8
pubmed: 10989268
Psychoneuroendocrinology. 2002 Jan-Feb;27(1-2):127-38
pubmed: 11750774
Depress Anxiety. 2002;15(3):117-25
pubmed: 12001180
Child Abuse Negl. 2003 Feb;27(2):169-90
pubmed: 12615092
Neuropsychopharmacology. 2003 Sep;28(9):1656-65
pubmed: 12838270
Behav Genet. 2003 Jul;33(4):421-33
pubmed: 14574141
Psychol Bull. 2004 May;130(3):355-91
pubmed: 15122924
Depress Anxiety. 2004;19(3):187-9
pubmed: 15129421
Nat Neurosci. 2004 Aug;7(8):847-54
pubmed: 15220929
Nat Genet. 2004 Dec;36(12):1319-25
pubmed: 15565110
Psychoneuroendocrinology. 2005 Aug;30(7):698-714
pubmed: 15854786
Nat Rev Neurosci. 2005 Jun;6(6):463-75
pubmed: 15891777
Psychoneuroendocrinology. 2005 Oct;30(9):857-68
pubmed: 15949896
Aust N Z J Psychiatry. 2005 Nov-Dec;39(11-12):964-71
pubmed: 16343296
Neuropsychopharmacology. 2006 Oct;31(10):2313-7
pubmed: 16794569
Psychoneuroendocrinology. 2006 Oct;31(9):1131-7
pubmed: 16997489
Brain Cogn. 2007 Dec;65(3):209-37
pubmed: 17466428
Physiol Rev. 2007 Jul;87(3):873-904
pubmed: 17615391
Neural Plast. 2007;2007:60803
pubmed: 17641736
Biol Psychiatry. 2007 Nov 15;62(10):1080-7
pubmed: 17662255
Brain Res Rev. 2008 Mar;57(2):561-70
pubmed: 17692926
Psychoneuroendocrinology. 2008 Feb;33(2):227-37
pubmed: 18096322
Arch Gen Psychiatry. 2008 Feb;65(2):190-200
pubmed: 18250257
J Endocrinol. 2009 Jan;200(1):3-22
pubmed: 18971218
Br J Psychiatry. 2008 Nov;193(5):378-82
pubmed: 18978317
Biol Psychiatry. 2009 Jul 1;66(1):62-8
pubmed: 19217075
Biol Psychiatry. 2009 Oct 1;66(7):681-5
pubmed: 19596121
Schizophr Bull. 2011 Mar;37(2):389-93
pubmed: 19687152
Psychol Med. 2010 Dec;40(12):2037-48
pubmed: 20132583
Soc Cogn Affect Neurosci. 2011 Apr;6(2):244-51
pubmed: 20400490
Behav Brain Sci. 2010 Jun;33(2-3):137-50; discussion 150-93
pubmed: 20584369
Am J Psychiatry. 2011 Jan;168(1):65-72
pubmed: 20952460
World Psychiatry. 2010 Oct;9(3):145-54
pubmed: 20975856
Physiol Behav. 2012 Apr 12;106(1):29-39
pubmed: 21888923
Dev Psychopathol. 2011 Nov;23(4):1017-37
pubmed: 22018079
Trends Cogn Sci. 2011 Dec;15(12):576-84
pubmed: 22078931
Science. 2011 Nov 25;334(6059):1151-3
pubmed: 22116887
Psychol Med. 2012 Sep;42(9):1857-63
pubmed: 22225730
Schizophr Bull. 2012 Mar;38(2):247-57
pubmed: 22258882
Br J Psychiatry. 2012 Jul;201(1):26-32
pubmed: 22500011
Psychol Med. 2013 Mar;43(3):449-69
pubmed: 22564216
Psychoneuroendocrinology. 2013 Jun;38(6):927-40
pubmed: 23122890
Psychopharmacology (Berl). 2013 May;227(2):231-41
pubmed: 23274505
Am J Psychiatry. 2013 Jul;170(7):734-41
pubmed: 23599019
Genes Brain Behav. 2014 Jan;13(1):25-37
pubmed: 24219237
Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3638-43
pubmed: 24550453
Psychoneuroendocrinology. 2014 Aug;46:32-45
pubmed: 24882156
Dev Psychopathol. 2014 Aug;26(3):605-18
pubmed: 25047287
Neurosci Biobehav Rev. 2014 Nov;47:359-68
pubmed: 25246294
Clin Psychol Sci. 2014 Mar;2(2):119-137
pubmed: 25360393
Psychol Med. 2015 May;45(7):1483-93
pubmed: 25394403
J Clin Epidemiol. 2015 Jun;68(6):627-36
pubmed: 25704724
Lancet Psychiatry. 2015 Dec;2(12):1112-6
pubmed: 26613851
PLoS One. 2017 Apr 12;12(4):e0175381
pubmed: 28403164
Horm Behav. 2018 Feb;98:63-76
pubmed: 29289660
Science. 1980 Dec 12;210(4475):1264-7
pubmed: 7434029
Neuropsychobiology. 1993;28(1-2):76-81
pubmed: 8255414
J Abnorm Psychol. 1998 May;107(2):216-27
pubmed: 9604551
Ann N Y Acad Sci. 1998 May 1;840:33-44
pubmed: 9629234
Dev Psychopathol. 1998 Spring;10(2):395-426
pubmed: 9635230
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538